FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/02/049505 [Registered on: 07/02/2023] Trial Registered Prospectively
Last Modified On: 07/02/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of application of Aloe Vera pulp (korfad) with Rakta Chandan and Triphala powder over eyelids in the treatment of DIGITAL EYE STRAIN. 
Scientific Title of Study   A Randomized Controlled Trial On Effect Of Kumaryadi Bidalaka In Comparison With CARBOXYMETHYLCELLULOSE Eye drops In The Treatment Of Digital Eye Strain W.S.R To SHUSHAKSHIPAKA. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priya Bhardwaj 
Designation  Pg Scholar 
Affiliation  Shri Ayurved Mahavidyalaya  
Address  Opd No. 11 Shalakya Tantra Department Shri Ayurved Mahavidyalaya kridasquare, Hanuman Nagar Nagpur
Shri Ayurved Mahavidyalaya kridasquare Hanuman Nagar Nagpur -440024
Nagpur
MAHARASHTRA
440024
India 
Phone  8368018073  
Fax    
Email  pb300995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Govind D Tundalwar 
Designation  Associate professor 
Affiliation  Shri Ayurved Mahavidyalaya  
Address  Opd No. 11 shalakya Tantra Department Shri Ayurved Mahavidyalaya kridasquare Hanuman Nagar Nagpur
Shri Ayurved Mahavidyalaya kridasquare Hanuman Nagar Nagpur -440024
Nagpur
MAHARASHTRA
440024
India 
Phone  9860166089  
Fax    
Email  drgovind2005@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Priya Bhardwaj 
Designation  Pg Scholar 
Affiliation  Shri Ayurved Mahavidyalaya  
Address  Opd No. 11 Shalakya Tantra Department Shri Ayurved Mahavidyalaya kridasquare Hanuman Nagar Nagpur
Shri Ayurved Mahavidyalaya kridasquare Hanuman Nagar Nagpur -440024
Nagpur
MAHARASHTRA
440024
India 
Phone  8368018073  
Fax    
Email  pb300995@gmail.com  
 
Source of Monetary or Material Support  
Opd No. 11, Shalakya Tantra Department ,Shri Ayurved Mahavidyalaya Hanuman Nagar Nagpur-440024 
 
Primary Sponsor  
Name  Dr. Priya Bhardwaj 
Address  Opd No. 11 Shalakya Tantra Department Shri Ayurved Mahavidyalaya kridasquare, Hanuman Nagar Nagpur -440024 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priya Bhardwaj  Shri Ayurved Mahavidyalaya  Opd No. 11 Shalakya Tantra Department Shri Ayurved Mahavidyalaya kridasquare, Hanuman Nagar Nagpur
Nagpur
MAHARASHTRA 
8368018073

pb300995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical Committee Of Shri Ayurved Mahavidyalaya, Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H041||Other disorders of lacrimal gland. Ayurveda Condition: SUSHKAKSHIPAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Carboxymethylcellulose eyedropCarboxymethylcellulose eyedrop - 1 drop TDS
2Intervention ArmProcedure-Bidalaka (Procedure Reference: Sharangdhara samhita uttartantra, Procedure details: Sharangdhara samhita uttartantra, Procedure details: Kumaryadi Bidalaka -Triphala churna and rakta chandan churna will be mixed with aloe vera pulp and fine paste will be applied over the eyelids.))
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  a)Patients having signs & symptoms of Digital Eye Strain.
b)Patients having age group of 16-60 years irrespective of their sex, caste, economical status & residence status.
c)Patients willing for treatment.
d)Patients having normal vision with or without spectacles.  
 
ExclusionCriteria 
Details  a)Patients not willing for clinical trial.
b)Patient suffering from other systematic disorders.
c)Patient undergone any intra ocular & extra ocular surgeries.
d)Patients having any ocular infectious /inflammatory disorders. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
This study may provide use of kumaryadi Bidalaka as an effective treatment in relieving the symptoms of Digital Eye Strain.  1 month 
 
Secondary Outcome  
Outcome  TimePoints 
Kumaryadi Bidalaka could be found effective in increasing the tear production by stimulating tear glands which are present in eyelids .   1 month 
 
Target Sample Size   Total Sample Size="78"
Sample Size from India="78" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   08/02/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NOT YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is an open label randomized controlled trial in which patients of Digital Eye strain would be taken from shalakyatantra opd no. 11 of shri Ayuved Mahavidyalaya Nagpur. Kumaryadi bidalaka will be given to the trial group for 15 days and Carboxymethylcellulose eyedrop will be given to the control group for 15 days and the results would be  compared on 30 th day. This study may provide use of kumaryadi Bidalka as an effective treatment in relieving the symptoms of digital eye strain and could be found effective in increasing the tear production. 
Close